Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT05261269 |
Title | A Dose-escalation Study of the Safety and Pharmacology of DAN-222 in Subjects With Metastatic Breast Cancer |
Recruitment | Completed |
Gender | female |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Dantari, Inc. |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
UC San Diego Moores Cancer Center | La Jolla | California | 92093 | United States | Details | |
UCLA - Parkside Cancer Center | Santa Monica | California | 90404 | United States | Details | |
H Lee Moffitt Cancer Center and Research Institute | Tampa | Florida | 33612 | United States | Details | |
University of Michigan | Ann Arbor | Michigan | 48109 | United States | Details | |
Saint Luke's Cancer Institute | Jackson | Missouri | 64111 | United States | Details | |
Icahn School of Medicine at Mount Sinai | New York | New York | 10029 | United States | Details | |
The University of Oklahoma Health Sciences Center | Oklahoma City | Oklahoma | 73104 | United States | Details | |
Magee Women's Hospital | Pittsburgh | Pennsylvania | 15232 | United States | Details | |
Sarah Cannon Research Institute/Tennessee Oncology | Nashville | Tennessee | 37203 | United States | Details |